Time and cost of administering COVID-19 mRNA vaccines in the United States

In early 2020, the World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) outbreak a global pandemic. In response, two novel messenger RNA (mRNA)-based vaccines: mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) were rapidly developed. A thorough understanding of the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarnoff, Benjamin, Bodhaine, Steven, Cohen, Ed, Buck, Philip O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828150/
https://www.ncbi.nlm.nih.gov/pubmed/34613860
http://dx.doi.org/10.1080/21645515.2021.1974289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828150/
https://www.ncbi.nlm.nih.gov/pubmed/34613860
http://dx.doi.org/10.1080/21645515.2021.1974289

Ejemplares similares